Amunix, Inc. Announces Licensing Agreement for Its Proprietary XTEN Technology
1/22/2013 9:54:35 AM
More...
|
Amunix, Inc. Signs Research Collaboration With Biogen Idec, Inc. (California) (BIIB) for Next Generation Long-Lasting Blood Factor Products
4/13/2011 9:21:33 AM
More...
|
Index Ventures and Amunix, Inc. Invest in New Company, Diartis Pharmaceuticals
2/16/2011 8:26:02 AM
More...
|
XTEN Data From Amunix, Inc. and Versartis, Inc. Featured in Nature Biotechnology as a Novel Platform for Increasing Serum Half-Life of Protein Therapeutics
11/16/2009 11:00:57 AM
More...
|